
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.680 | 0.750 | 0.070 |
Shares | 99.320 | 99.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.077 | 20.148 |
Price to Book | 3.911 | 3.965 |
Price to Sales | 1.682 | 2.369 |
Price to Cash Flow | 16.237 | 16.043 |
Dividend Yield | 1.351 | 1.392 |
5 Years Earnings Growth | 10.713 | 11.622 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.17 | 776.72 | +0.21% | |
Novo Nordisk B | DK0062498333 | 6.66 | 437.5 | -2.09% | |
J&J | US4781601046 | 6.43 | 157.30 | +1.83% | |
AstraZeneca | GB0009895292 | 6.35 | 10,294.0 | -2.00% | |
Roche Holding Participation | CH0012032048 | 6.02 | 262.80 | -1.28% | |
Thermo Fisher Scientific | US8835561023 | 3.70 | 407.85 | +0.20% | |
Lonza Group | CH0013841017 | 3.49 | 574.80 | -0.52% | |
UnitedHealth | US91324P1021 | 3.42 | 391.06 | -0.87% | |
Sanofi | FR0000120578 | 2.84 | 92.07 | +0.44% | |
Medtronic | IE00BTN1Y115 | 2.53 | 83.16 | +1.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 110.73B | -9.11 | 14.38 | 12.31 | ||
DNB Teknologi NOK | 72.36B | -8.71 | 21.07 | 19.68 | ||
Pensjonsprofil 80 | 50.79B | -1.11 | 6.91 | 8.11 | ||
DNB Global IV | 40.83B | -6.75 | 15.22 | 12.70 | ||
Pensjonsprofil 50 | 28.29B | -0.08 | 5.48 | 6.14 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review